Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Barber

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
BJU International|November 19, 2016
Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized studyChristian Gratzke, Neil Barber, Mark J Speakman, et al.
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
Urology|August 13, 2023
Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical OutcomesIman Sadri, Anindyo Chakraborty, David-Dan Nguyen, et al.
Journal of Endourology|September 26, 2022
Aquablation Treatment for Benign Prostate Hyperplasia: Current Standardized ProcedureKevin C Zorn, Dean Elterman, Ricardo Gonzalez, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2024
AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese PopulationNobuyuki Hinata, Masato Fujisawa, Raizo Yamaguchi, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
BJU International|November 19, 2016
Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized studyChristian Gratzke, Neil Barber, Mark J Speakman, et al.
The Canadian Journal of Urology|February 12, 2022
Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPHPeter J Gilling, Neil Barber, Mohamed Bidair, et al.
Urology|August 13, 2023
Aquablation in Patients on Antithrombotics: Assessment of Safety, Postoperative Bleeding Rates and Clinical OutcomesIman Sadri, Anindyo Chakraborty, David-Dan Nguyen, et al.
Journal of Endourology|September 26, 2022
Aquablation Treatment for Benign Prostate Hyperplasia: Current Standardized ProcedureKevin C Zorn, Dean Elterman, Ricardo Gonzalez, et al.
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2024
AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese PopulationNobuyuki Hinata, Masato Fujisawa, Raizo Yamaguchi, et al.
BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.
Pageof 6